Detalhe da pesquisa
1.
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma.
Br J Cancer
; 128(5): 907-917, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36526676
2.
A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma.
J Hepatol
; 70(5): 904-917, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30654066
3.
Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1.
Hepatology
; 63(2): 499-511, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25964079
4.
Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma.
Mol Cancer
; 14: 170, 2015 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26376879
5.
Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling.
Mol Carcinog
; 54(12): 1584-95, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25307746
6.
Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy.
Hepatology
; 56(6): 2231-41, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22706893
7.
Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study.
Front Immunol
; 14: 1198562, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37483609
8.
Perioperative and long-term survival outcomes of laparoscopic versus open hepatectomy for BCLC stage A large hepatocellular carcinoma patients in difficult segments: A two-centre, propensity score matching analysis.
Front Oncol
; 13: 1095357, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36969010
9.
The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
Pathol Res Pract
; 236: 153989, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35753134
10.
Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3â¯cm - A retrospective cohort study.
Am J Surg
; 219(4): 717-725, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31266631
11.
The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1.
Nat Cell Biol
; 19(7): 820-832, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28553938
12.
Paraoxonase 3 inhibits cell proliferation and serves as a prognostic predictor in hepatocellular carcinoma.
Oncotarget
; 7(43): 70045-70057, 2016 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27661119
13.
Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.
Nat Commun
; 7: 12992, 2016 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27703150
14.
Antisense long non-coding RNA PCNA-AS1 promotes tumor growth by regulating proliferating cell nuclear antigen in hepatocellular carcinoma.
Cancer Lett
; 349(1): 87-94, 2014 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24704293
15.
Low CADM2 expression predicts high recurrence risk of hepatocellular carcinoma patients after hepatectomy.
J Cancer Res Clin Oncol
; 140(1): 109-16, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24240726
16.
A long noncoding RNA activated by TGF-ß promotes the invasion-metastasis cascade in hepatocellular carcinoma.
Cancer Cell
; 25(5): 666-81, 2014 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24768205
17.
Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.
Nat Commun
; 7: 13591, 2016 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27824035